These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17704546)
1. Vascular endothelial growth factor (VEGF) & tumour angiogenesis. Moulik S; Chatterjee A Indian J Med Res; 2007 Jun; 125(6):715-6. PubMed ID: 17704546 [No Abstract] [Full Text] [Related]
2. Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients. Konukoglu D; Turhan MS; Celik V; Turna H Indian J Med Res; 2007 Jun; 125(6):747-51. PubMed ID: 17704550 [TBL] [Abstract][Full Text] [Related]
3. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086 [TBL] [Abstract][Full Text] [Related]
4. The critical role of vascular endothelial growth factor in tumor angiogenesis. Amini A; Masoumi Moghaddam S; Morris DL; Pourgholami MH Curr Cancer Drug Targets; 2012 Jan; 12(1):23-43. PubMed ID: 22111836 [TBL] [Abstract][Full Text] [Related]
5. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis? Pawlak K; Ulazka B; Mysliwiec M; Pawlak D Transl Res; 2012 Nov; 160(5):346-54. PubMed ID: 22683425 [TBL] [Abstract][Full Text] [Related]
7. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects. Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003 [TBL] [Abstract][Full Text] [Related]
8. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis. Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591 [TBL] [Abstract][Full Text] [Related]
9. [Angiogenesis and metastasis of carcinoma]. Chen L; Shibasaki F Clin Calcium; 2006 Apr; 16(4):613- 19. PubMed ID: 16582512 [TBL] [Abstract][Full Text] [Related]
10. Microenvironmental and cellular consequences of altered blood flow in tumours. Raghunand N; Gatenby RA; Gillies RJ Br J Radiol; 2003; 76 Spec No 1():S11-22. PubMed ID: 15456710 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-driven selection of the metastatic phenotype. Sullivan R; Graham CH Cancer Metastasis Rev; 2007 Jun; 26(2):319-31. PubMed ID: 17458507 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Mizukami Y; Kohgo Y; Chung DC Clin Cancer Res; 2007 Oct; 13(19):5670-4. PubMed ID: 17908955 [TBL] [Abstract][Full Text] [Related]
13. Molecular regulation of tumour angiogenesis by nitric oxide. Ziche M; Morbidelli L Eur Cytokine Netw; 2009 Dec; 20(4):164-70. PubMed ID: 20167555 [TBL] [Abstract][Full Text] [Related]
14. An integrative model for vascular endothelial growth factor A as a tumour biomarker. Latham AM; Molina-París C; Homer-Vanniasinkam S; Ponnambalam S Integr Biol (Camb); 2010 Sep; 2(9):397-407. PubMed ID: 20725676 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) in physiological and pathological conditions. Chodorowska G; Chodorowski J; Wysokiński A Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):8-14. PubMed ID: 16146041 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis. Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352 [TBL] [Abstract][Full Text] [Related]
18. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Vermeulen PB; Gasparini G; Fox SB; Toi M; Martin L; McCulloch P; Pezzella F; Viale G; Weidner N; Harris AL; Dirix LY Eur J Cancer; 1996 Dec; 32A(14):2474-84. PubMed ID: 9059336 [No Abstract] [Full Text] [Related]
19. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Loges S; Mazzone M; Hohensinner P; Carmeliet P Cancer Cell; 2009 Mar; 15(3):167-70. PubMed ID: 19249675 [TBL] [Abstract][Full Text] [Related]
20. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]